JAK2-binding long noncoding RNA promotes breast cancer brain metastasis
Shouyu Wang(Army Medical University), Chunru Lin(The University of Texas MD Anderson Cancer Center), Elsa R. Flores(Moffitt Cancer Center), Jun Yao(The University of Texas MD Anderson Cancer Center), Wenhao Yang(Fujian Agriculture and Forestry University), Yuedong Yang(Guangzhou Experimental Station), Gabriel Lopez‐Berestein(The University of Texas MD Anderson Cancer Center), Jeffrey R. Marks(Duke Medical Center), David H. Hawke(The University of Texas MD Anderson Cancer Center), Dihua Yu(The University of Texas MD Anderson Cancer Center), Lingegowda S. Mangala, Liuqing Yang(Southern University of Science and Technology), Ke Liang(The University of Texas MD Anderson Cancer Center), Mien‐Chie Hung(Precision Therapeutics (United States)), Qingsong Hu(The University of Texas MD Anderson Cancer Center), Ping Li(Second Affiliated Hospital of Hunan University of Traditional Chinese Medicine), Anil K. Sood(The University of Texas MD Anderson Cancer Center), Jianwei Zhou(Second Affiliated Hospital of Zhejiang University), Chunlai Li(The University of Texas MD Anderson Cancer Center), Jian H. Song(The University of Texas MD Anderson Cancer Center), Yan Zhou(Nanchang University), Peter K. Park(The University of Texas MD Anderson Cancer Center), Gary E. Gallick(The University of Texas MD Anderson Cancer Center), Weiya Xia(The University of Texas MD Anderson Cancer Center), Suyun Huang(Virginia Commonwealth University)
Cited by 231
Related Papers
Monitoring dopants by Raman scattering in an electrochemically top-gated graphene transistor
|Nature Nanotechnology|2008|3.6k
PTEN activation contributes to tumor inhibition by trastuzumab, and loss of PTEN predicts trastuzumab resistance in patients
|Cancer Cell|2004|1.9k
Rethinking ovarian cancer: recommendations for improving outcomes
|Nature reviews. Cancer|2011|1.5k
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer
|Nature reviews. Cancer|2015|1.4k
Molecular Definition of Breast Tumor Heterogeneity
|Cancer Cell|2007|1.4k